Pieris Pharmaceuticals Retained Earnings (Accumulated Deficit) 2014-2024 | PVLA

Pieris Pharmaceuticals retained earnings (accumulated deficit) from 2014 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Pieris Pharmaceuticals Retained Earnings (Accumulated Deficit) 2014-2024 | PVLA

Pieris Pharmaceuticals retained earnings (accumulated deficit) from 2014 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Related Stocks
Company NameMarket
Cap
NPK (NPKI)$626M
Performant Healthcare (PHLT)$245M
FTAC Emerald Acquisition (FLDD)$158M
Swiftmerge Acquisition (ANNA)$42M
Insight Acquisition (AMOD)$23M
Hanryu Holdings (GITS)$17M
LQR House (YHC)$11M
ATIF Holdings (ZBAI)$9M
Lion Electric (LEVGQ)$0M